Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Tofacitinib impurity J

Tofacitinib impurity J is listed under Impurity and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Tofacitinib. The product is supplied by Clearsynth under CAT No. CS-AQ-00039. Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.

Product Specifications

Overview

Useful research chemical for a range of applications.

CAS Number

1431697-80-1

Synonyms

Tofacitinib impurity J

Molecular Formula

C 14 H 22 N 2 : 2 (HCl)

Molecular Weight

218.3 : 2 (36.5)

Additionnal Information

Tofacitinib impurity J is supplied with detailed characterization data compliant with regulatory guideline. Tofacitinib impurity J can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Tofacitinib.

Storage Conditions

Refer MSDS for complete information.

Applications Notes

Useful research chemical for a range of applications.

HSN Code

38229010

Hazard Compound

Refer MSDS for complete information.

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

anti-TPP1
YF-PA10993 100 ug

anti-TPP1

Sign In for Pricing
View Details
NPHS2 Antibody
MBS9406921-01 0.1 mL

NPHS2 Antibody

Sign In for Pricing
View Details
NPHS2 Antibody
MBS9406921-02 5x 0.1 mL

NPHS2 Antibody

Sign In for Pricing
View Details
NTF4 Antibody, HRP conjugated
A43869-100UG 100 µg

NTF4 Antibody, HRP conjugated

Sign In for Pricing
View Details
TAAR1 Antibody - N-terminal region
ARP78246_P050-25UL 25 µL

TAAR1 Antibody - N-terminal region

Sign In for Pricing
View Details
Insulin antibody
10-I30B 1 mg

Insulin antibody

Sign In for Pricing
View Details